In breast cancer, it inhibits cell proliferation, migration, and invasion, with overexpression linked to improved survival outcomes and acting as an independent prognostic factor by regulating the EGFR/Akt pathway [41]. This evidence concerns the gene EGFR and breast carcinoma.